Copper carbenes alkylate guanine chemoselectively through a substrate directed reaction by Geigle, Stefanie et al.
Chemical
Science
EDGE ARTICLE
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
7 
Se
pt
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 2
7/
02
/2
01
7 
13
:0
9:
34
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e. View Article Online
View Journal  | View IssueCopper carbenesaDepartment of Chemistry, University of Bas
Switzerland. E-mail: dennis.gillingham@un
bDepartment of Health Sciences and Techno
CH-8092 Zurich, Switzerland
† Electronic supplementary informati
experimental details and characterization
Cite this: Chem. Sci., 2017, 8, 499
Received 5th August 2016
Accepted 2nd September 2016
DOI: 10.1039/c6sc03502g
www.rsc.org/chemicalscience
This journal is © The Royal Society of Calkylate guanine
chemoselectively through a substrate directed
reaction†
Stefanie N. Geigle,a Laura A. Wyss,b Shana J. Sturlab and Dennis G. Gillinghama
Cu(I) carbenes derived from a-diazocarbonyl compounds lead to selective alkylation of the O6 position in
guanine (O6-G) in mono- and oligonucleotides. Only purine-type lactam oxygens are targeted – other
types of amides or lactams are poorly reactive under conditions that give smooth alkylation of guanine.
Mechanistic studies point to N7G as a directing group that controls selectivity. Given the importance of
O6-G adducts in biology and biotechnology we expect that Cu(I)-catalyzed O6-G alkylation will be
a broadly used synthetic tool. While the propensity for transition metals to increase redox damage is
well-appreciated, our results suggest that transition metals might also increase the vulnerability of
nucleic acids to alkylation damage.Introduction
Catalytic reactions with metal carbenes are broadly applied in
synthetic chemistry.1,2 Although metal carbenes are reactive
intermediates, their chemoselectivity can be steered through the
right combination ofmetal, ligand, and carbene precursor.3 Even
in water metal carbenes can still perform an impressive array of
transformations.4–7 In our studies on the post-synthetic tailoring
of large nucleic acids through metal catalysis we have found that
donor–acceptor substituted carbenes8 derived from Rh(II) and
Cu(I) give primarily N–H insertion of exocyclic amine groups in
unpaired regions of DNAs and RNAs.9–11 Here we show that
unstabilized Cu(I) carbenes derived from a-diazo acetate and
amide derivatives have a completely diﬀerent chemoselectivity:
they quickly and cleanly alkylate the O6 position in guanine and
inosine (see Fig. 1B for a representative reaction with GMP and
ethyl a-diazoacetate (EDA)). Cu(I) is known to bind amides
(especially amidates),12 but there is no precedence which would
have predicted such a pronounced selectivity for the lactam-like
oxygen of guanine. While most instances of copper13 direction by
heterocycles in synthetic chemistry14–16 and biology17,18 employ
histidine or pyridine (see Fig. 1A), our results show that the
purine ring system of guanine is also a powerful directing group
in copper catalysed alkylation (see Fig. 1B) reactions.
DNA is constantly exposed to electrophiles, both natural
and man-made.19 In response, all organisms have evolvedel, St. Johanns-Ring 19, CH-4056, Basel,
ibas.ch
logy, ETH Zurich, Schmelzbergstrasse 9,
on (ESI) available: For complete
data. See DOI: 10.1039/c6sc03502g
hemistry 2017DNA surveillance and repair pathways to maintain genomic
integrity.20 Alkylation at the O6 of guanine21 is particularly
dangerous because polymerases tend to misincorporate thymi-
dines in response to O6-(alkyl)-G during replication, leading toFig. 1 (A) In both synthetic chemistry and biology there are numerous
examples of copper chemistry being controlled by coordination to
nitrogen heterocycles (PDB ID: 1YEW) (B) N7 of guanines and inosines
can direct copper catalysed reactions to the O6 position.
Chem. Sci., 2017, 8, 499–506 | 499
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View Article Onlinepotentially carcinogenic G-to-A transition mutations.22–25 The
colon cells of people on high red meat diets have increased
carboxymethyl damage at O6-G.26,27 Epidemiological studies have
shown that the high-red meat diet demographic in Western
cultures suﬀer as well from a higher prevalence of gastrointes-
tinal cancers.28,29 Whether there is a causative connection
between these two occurrences is currently unclear. Studying the
biology of O6-(carboxymethyl)-G damage (O6-cmG), however, is
hampered by synthetic challenges. Multi-step procedures, pro-
tecting group manipulations,30 and the need for strong electro-
philic phosphorous reagents,31 combine to make both the
synthesis and purication of O6-(alkyl)-G derivatives laborious.
With copper catalysed alkylation the carboxymethyl motif is
introduced in a single step from naturally occurring precursors.Results and discussion
Reaction discovery and substrate scope
Cu(I) carbenes derived from a-diazocarbonyl compounds are
highly selective for O6 alkylation of unpaired guanines and
inosines in ssDNA, monophosphates (MP) and triphosphates
(TP) (see Fig. 1B and Table 1). The surprising selectivity
prompted us to synthesize an O6-alkyl-inosine adduct byTable 1 Reactions of ethyl a-diazoacetate (EDA) with mono- and
oligonucleotides
Entry Substrate Time (min) Cosolvent Conv. (%) Yield. (%)
1a dGMP 30 None 98e 86
2a GMP 30 None 96e 92
3b GMP 30 DMSO 93e —
4c GMP 30 None 87 (ref. 32) —
5d GMP 150 None 0 —
6a IMP 30 None 92e 81
7a AMP 30 None 40 —
8a CMP 30 None 38 —
9a UMP 30 None 21 —
10a TMP 30 None 13 —
11b GTP 30 tBuOH 98e 73
12b dGTP 30 tBuOH 97e 65
13a d(TGT) 15/45 None 62/81e —
14a d(TAT) 120 None 35f —
15b d(ATGC) 150 tBuOH 38e —
16b d(ATGC) 150 Dioxane 64e —
17b d(TTTTGTTTT) 30 DMSO 82e —
a Complete conditions: 5 mM substrate, 1 mM CuSO4, 5 mM ascorbate,
50 mM EDA (ethyl diazoacetate), 100 mM MES (2-(N-morpholino)
ethanesulfonic acid) pH 6, H2O, 25 C.
b Same conditions as a but
with 20% (v/v) of cosolvent. c No ascorbate added. d No CuSO4 or
ascorbate added. e Alkylation site was assigned on the basis of
tandem MS fragmentation ions. f Six minor mono-alkylation products
were detected by ESI, but none in an amount that could be isolated.
500 | Chem. Sci., 2017, 8, 499–506traditional routes to check the site-selectivity: identical charac-
terization data conrm the proposed structures (see the ESI,†
page S5-6). The method is the most concise and selective
approach ever reported to the O6-(alkyl)-G motif and it is post-
synthetic, obviating the need for solid phase DNA synthesis with
modied phosphoramidites. The convergent assembly opens
the door to a range of O6-(alkyl)-G derivatives from simple
starting materials.
We explored the eﬃciency and selectivity of O6-G targeting by
characterizing reactions with nucleotide monophosphates.
Treatment of dGMP or GMP with 20 mol% Cu(II)SO4 (in situ
reduced by ascorbate) and ethyl a-diazoacetate (EDA) in
aqueous buﬀer resulted in high conversion and isolated yields
of ethylcarboxymethyl product (see Table 1, entry 1 and 2)
within 30 min. Under the same conditions, the structural
analogues IMP, GTP, and dGTP were eﬃciently alkylated at
their O6 positions (see Table 1, entry 6, 11 and 12). In contrast,
reactions without catalyst (entry 5) or with diﬀerent MPs like
UMP, AMP, CMP, or TMP (entries 7–10) resulted in little or no
detectable alkylation. Rather, in cases where substrates lacked
a guanine, the starting material was partially converted through
unselective pathways that we could not completely characterize
– in each case some alkylation was usually observed in the MS
but these did not give substantial HPLC peaks that we could
isolate. The same was also seen in short DNA fragments such as
d(TAT) (see entry 14); here again starting material was
consumed over time, but no single alkylation product could be
isolated. In contrast, when guanine was present post-synthetic
modications of a DNA 3-mer d(TGT) and 9-mer d(TTTTGTTTT)
with the EDA-derived Cu(I) carbene gave a single large alkylation
product (only O6-G alkylation observed, see Table 1 entries 13
and 17). In the substrates that lack guanine we cannot account
for the mass balance: we believe in these cases that oxidation is
a side-reaction that consumes starting material when no
guanine is available for the carbene-based reaction.Cosolvent, oligonucleotide size, and diazo substrate all
modulate reactivity
While oligonucleotides also reacted selectively at O6-G, the
reactions were slower. For example, d(ATGC) was alkylated at
O6-G (determined by MS-MS sequencing, see ESI page S18†) but
required longer reaction times and conversion was lower than for
the mononucleotides (cf. Table 1 entries 11 & 15). This reduced
reactivity can likely be attributed to the unproductive sequestra-
tion of copper to other binding sites (phosphate backbone, other
nucleobases) in the nucleic acid. The lower reactivity with longer
oligonucleotides was mitigated by using 1,4-dioxane as a cosol-
vent. For example, changing the stock solution of EDA from 10%
tBuOH in water to dioxane nearly doubled the conversion of
d(ATGC) (cf. Table 1 entries 15 & 16). Nevertheless, these obser-
vations point to a limitation of the method: the larger the
oligonucleotide the slower it is likely to react.
Diazo substrate variation is another approach to improve the
reaction with challenging nucleic acid substrates. Diazo-
acetamides33 (DAAs) led to higher conversions than EDA and
high O6 selectivity was maintained (see Table 2). For example,This journal is © The Royal Society of Chemistry 2017
Table 2 Reactions of diazo acetamides (DAAs) with oligonucleotides
Entry Substrate Diazo compound Time (min) Conv. (%)
1 d(TGT) 15 78b
2 d(TGT) 15 78b
3 d(ATGC) 150 62b
4 d(ATGC)c 30 74b
5 d(ATGC) 150 61b
6 d(TTTTGTTTT) 30 92b
7 d(TTTTGTTTT) 30 81b
8 d(AACAGTCATATCCTTA) 180 48
9 d(AACAGTCATATCCTTA) 180 40
10 d(ATGC)c 150 66b
a Complete conditions: 5 mM substrate, 1 mM CuSO4, 5 mM ascorbate, 50 mM diazo compound, 100 mMMES pH 6, DMSO 20% (v/v), H2O, 25 C.
b G-alkylation was assigned on the basis of tandem MS fragmentation ions. c Same conditions as a but with 20% (v/v) dioxane instead of DMSO.
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View Article Onlinethe alkylation of d(ATGC) with DAAs led to conversions of
starting material above 60% (see entries 3 & 5, Table 2), whereas
the same substrate with EDA led to only 38% conversion (see
entry 15, Table 1). While DAAs are better substrates in nucleic
acid alkylation, they are also less stable; it was, for example,
impossible to prepare a stock solution in 10% tBuOH and water
due to rapid decomposition. DMSO as co-solvent stabilizes the
DAAs, with the drawback that their reactivity in nucleic acid
alkylation is reduced. Changing to a less coordinating co-
solvent like dioxane seems to be the best compromise between
these competing eﬀects. For example comparing entries 3 & 4 in
Table 2 we see that in 20% dioxane higher conversion was ob-
tained in a h of the time (62% aer 150 minutes versus 74%
aer 30 minutes). With the more reactive DAAs, even longerThis journal is © The Royal Society of Chemistry 2017DNAs such as 16-mers were alkylated eﬃciently (see entries 8 &
9, Table 2). The amide substrates oﬀer the additional advan-
tages of stability and modularity. Customization of substrates
for pull-downs or with uorescent tags would simply require the
addition of the appropriate amine in the DAA synthesis.33 As an
example, modication of guanine at the O6 position of d(ATGC)
with a terminal alkyne-bearing diazo substrate (see entry 10,
Table 2) followed by a click reaction with azide-conjugated
biotin (see the ESI page S31†), installed a complex pull-down tag
in only two steps.
Mechanistic hypothesis
The selectivity observed with copper carbenes does not reect
the intrinsic nucleophilicity of DNA nucleophiles.34 In studiesChem. Sci., 2017, 8, 499–506 | 501
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View Article Onlinewith powerful alkylating agents, it has been established that
N7G is the most potent nucleophile in both dsDNA and ssDNA.
O6-G alkylation is found ve to tenfold less, while the remaining
heteroatoms account for approximately ve percent of alkyl-
ation products.21 Since unstabilized Cu(I) carbenes should be
highly reactive with water, we expected that the selectivity might
stem from pre-association of copper with the guanine nucleo-
base. Guanine is the most electron rich of the nucleobases and
readily chelates with divalent metals, including copper(II).35,36
DFT calculations of molecular dipoles in DNA bases indicate
that guanine has the largest molecular dipole (6.9 D) and its
negative pole is located between O6 and N7. On the other hand,
little is known about the interaction of Cu(I) with DNA,37 likely
because the Cu(I) oxidation state has limited stability in
aqueous buﬀer at neutral pH (it tends to oxidize or dispropor-
tionate)38 and is therefore diﬃcult to study. Nevertheless, based
on analogy to Cu(II), which readily binds guanine N7s, we
hypothesize that the selectivity derives from carbene formation
with an N7 bound copper atom. Crystal structure data for
Cu(II)39 and other divalent metals36 show a strong preference for
N7G coordination, with a consequent positioning of the metal
approximately 3.5 A˚ away from O6. The bound carbene would be
thus poised to form ametal ylide with the O6 position (see lower
mechanistic scheme in Fig. 2), and an irreversible protonation
would complete the alkylation.
The selectivity that we observe mirrors the preference in sites
of Cu-catalysed oxidative (peroxide or superoxide) damage in
DNA, which show increased oxidation at and around guanine
residues.40 The research on copper-mediated redox damage
supports two main pathways. In the rst an unbound copper(I)
ion releases reactive oxygen species upon oxygen reduction or
hydrogen peroxide cleavage, the resulting hydroxyl radical
diﬀuses to the nearest site on DNA and typically leads to DNA
fragmentation. This mechanism is unselective and presents
a constant danger to DNA and RNA – it is, however, ineﬃcient.
In the second mechanism a guanine-bound copper(I) forms
a copper(II) oxo complex by reacting with peroxide, leading to
oxidative damage of the guanine itself as well as neighbouring
bases. These reports on oxidative damage, however, provided noFig. 2 Mechanistic proposal accounting for the high O6-G chemo-
selectivity. Electrostatic potential map and the molecular dipole
moment (6.9 D) were calculated in Spartan014 with DFT calculations at
the EDF2 6-31G* level of theory using 9-methylguanine.
502 | Chem. Sci., 2017, 8, 499–506insight on why guanine was the target or how the copper bound.
We propose that both the specicity of oxidative damage
observed in earlier reports and the alkylation specicity we
observe here is a result of the same thing: guanine's superior
ability to coordinate copper.
The hypothesis that guanine pre-coordination controls che-
moselectivity would predict the following:
(1) Other amide or lactone substrates that lack the strong
coordination ability of guanine should be poorly reactive.
(2) Strongly chelating multidentate ligands should be dele-
terious to reactivity, since the combination of the guanine and
the multidentate ligand would not leave space in copper's
coordination environment for carbene formation.
Over the next two sections we will examine experimental data
for each of these scenarios and demonstrate that the hypothesis
holds.
1. Normal amide or lactone substrates are poorly reactive.
The most compelling example for the importance of N7G
coordination is the 7-deaza-20-deoxyguanosinetriphosphate
(deaza-dGTP), which shows substantially reduced reactivity and
selectivity in comparison to normal guanine (see the HPLC
traces in Fig. 3). The simple thymidine substrate as well as the
cyclic lactam piperidin-2-one are similarly unreactive, adding
further weight to the idea that the N7 coordination is the
decisive factor in O6 alkylation specicity. Although no litera-
ture precedence exists for this Cu(I)-based mechanism, a recent
report has shown that histidine residues in proteins can control
selectivity in the Cu(II)-catalysed alkenylation reaction of the
amide backbone.16
2. Multidentate ligands inhibit and N-heterocyclic carbene
(NHC) ligands promote guanine alkylation. The copper-cata-
lysed azide alkyne cycloaddition (CuAAC) is a widely used ligation
reaction in chemical biology. Ligands such as bathocuproine andFig. 3 Substrate-based mechanistic probes point to the role of the N7
of guanine in directing the chemoselectivity. Only the dGMP starting
material leads to eﬃcient reaction. HPLC traces were recorded after
30 min reaction time. Reaction conditions: 5 mM substrate (dGMP or
deaza-dGTP or TMP or a-valerolactone), 1 mM CuSO4, 5 mM ascor-
bate, 50 mM EDA, 100 mM MES pH 6, dioxane 20% (v/v), H2O, 25 C.
This journal is © The Royal Society of Chemistry 2017
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View Article Onlinetristriazoles are oen used to stabilize Cu(I) and accelerate the
reaction.41–43 In our case, however, the addition of strongly
coordinating ligands such tris(3-hydroxypropyltriazolylmethyl)
amine (THPTA) or bathocuproinedisulfonic acid disodium salt
(BCA) lead to a suppression of guanine alkylation. Even aer
several hours little or no alkylation product could be detected
(see Fig. 4A). In the case of THPTA the copper carbene was still
formed (see disappearance of EDA inHPLC trace) but no guanine
alkylation was observed. Instead the diazo compound is
consumed in unproductive decomposition reactions.
A copper catalyst bearing an N-heterocyclic carbene (NHC)
ligand behaved diﬀerently: mesitylimidazolinium copper chlo-
ride (MesCuCl) gave the same alkylation prole as the standard
‘ligandless’ conditions, with O6-G alkylation being the domi-
nant product (see Fig. 4B). It is revealing that the NHC ligand,
which is not bidentate and hence would still allow coordination
with N7G, is the only type tested that maintained alkylation
activity. The NHC ligands have other favourable properties for
the alkylation reaction (such as reducing oxidative damage) and
we are currently exploring the full potential of NHC ligands in
DNA and RNA alkylation.Biochemical studies with O6-(alkyl)-G adducts
With ready access to O6-G derivatives we next used the products
to study two open questions in the biochemistry of O6-G
adducts: rst, their repair by alkylguanine transferases (AGTs)
and second, their incorporation during DNA replication.Fig. 4 (A) Multidentate ligands like THPTA and bathocuproine disul-
fonic acid disodium salt (BCA) suppress dGMP alkylation. (B) dGMP
alkylation catalysed by MesCuCl is highly eﬃcient. HPLC trace was
recorded after 30 minutes reaction time.
This journal is © The Royal Society of Chemistry 2017Human AGT repairs peptide-like carboxamide adducts
AGTs are found in all domains of life and are responsible for
repairing O6-G adducts in the genome. Human AGT (hAGT)
repairs O6-(alkyl)-G adducts from single stranded and duplex
DNAs.44–47 The repair pathway is important since polymerases
oen mis-incorporate T when bypassing this lesion during
replication.48,49 Evolution has found no eﬀective catalytic
solution to the direct reversal of O6-G damage; instead AGT acts
as a suicide protein. It bears a nucleophilic cysteine that
attacks the alkyl group of the adduct and restores the native
guanine.44 Previous reports conict as to whether carbox-
ymethyl damage is repaired by hAGT.50,51 In addition, since
diazotized peptides are the likely source of these alkylation
adducts,26,50 it is important to understand whether adducts
bearing amides are also eﬀectively repaired. Bacteria also
produce diazo peptide natural products that may alkylate
DNA,52,53 adding additional impetus to understand the repair of
amide adducts. Thus, we tested whether a DNA 9-mer modied
with a cyclohexyl carboxymethylamide (see Table 2, entry 6),
was a substrate for hAGT (see Fig. 5). Although removal of the
adduct was slow (reduced rates are expected for ssDNAs),54
analysis of both the deoxyoligonucleotide (see panel B in Fig. 5)
and the protein (see panel C in Fig. 5) indicate repair occurred.
These results support the most recent claim that carbox-
ymethyl adducts are indeed repaired,51 and it adds the car-
boxymethyl amide motif to the list of deoxyoligonucleotides
repaired by hAGT.Fig. 5 (A) De-alkylation of O6-G modiﬁed ssDNA 9 mer by hAGT at 37
C. (B) HPLC analysis of the reaction mixture after 0 (green), 0.5
(purple) and 4 hours (red). (C) High resolution ESI-MS from hAGT after
4 h at 37 C (the second set of peaks derive from a post-translational
modiﬁcation (likely methylation) of hAGT that we cannot identify, but
which has no eﬀect on its function since both masses shift after the
dealkylation).
Chem. Sci., 2017, 8, 499–506 | 503
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View Article OnlineO6-G alkylated triphosphates can be misincorporated during
DNA synthesis
To test the impact of O6-alkylation on nucleotide incorporation
during DNA synthesis, we characterized O6-(alkyl)-G triphos-
phates as polymerase substrates. Thus, we synthesized the
modied deoxynucleotidetriphosphates O6-(ethyl carboxymethyl)-
dGTP and (O6-(ethylcm)-dGTP) and O6-(carboxymethyl)-dGTP
(O6-(cm)-dGTP) with our Cu(I) carbene methodology. Selective
carboxymethylation of commercial dGTP at the O6 position with
EDA as carbene precursor directly delivers O6-(ethylcm)-dGTP and
a subsequent ester hydrolysis yields O6-(cm)-dGTP; hence both
molecules are obtained in a total of two chemical operations (see
Fig. 6A). The direct modication approach oﬀers unprecedented
eﬃciency in the formation of O6-G adducts (in this case from
a commercial triphosphate without any protecting group or
phosphorylation steps). Previous syntheses of O6-G modied
nucleosides and triphosphates involved four31 to seven55–58 steps
including triphosphate introduction using strong electrophilic
phosphorous reagents.59
To investigate the incorporation of O6-(cm)-dGTP and
O6-(ethylcm)-dGTP during DNA synthesis, we performed single
nucleotide primer extension experiments with KTqM747K,
a mutant of KlenTaq polymerase that bypasses several DNA
modications.60–62 Unmodied 28-mer templates (50-ATT ATG
CTG AGT GAT ATC CCT CTX CTC A) in which X ¼ G, A, T or CFig. 6 (A) Synthesis of O6-(alkyl)-dGTPs with a Cu(I) carbene derived
from EDA. (B) Single nucleotide primer extension with O6-(alkyl)-
dGTPs opposite DNA templates G, A, T, and C catalyzed by KTqM747K.
Reactions were performed at 55 C for 10 min and contained 50 mM
dNTPs. (C) PAGE analysis of the primer extension experiment. M, blank
corresponding to 23 nt primer.
504 | Chem. Sci., 2017, 8, 499–506were annealed to a 50-end [g-32P] radiolabeled 23-mer primer (50-
AGA GGG ATA TCA CTC AGC ATA AT) and then subjected to
primer extension conditions (see Fig. 6B). Reaction products
were separated by denaturing polyacrylamide gel electropho-
resis and visualized with phosphorimaging. Nucleotides
O6-(cm)-dGTP as well as O6-(ethylcm)-dGTP were incorporated
opposite both C and T, but C was especially well tolerated.
Furthermore, whereas with T incorporation the polymerase
stalls aer the rst extension, the O6-(alkyl)-G:C mismatch
seems to pose no problem for the polymerase's procession since
the second extension also occurs quickly (see the C lane in
Fig. 6C). Consistent with steric matching as a key component in
polymerase delity,63–66 purine mismatches were poorly toler-
ated (see G and A bands in the gel in Fig. 6C). These experiments
serve as the proof-of-concept that O6-(cm)-G damaged nucleo-
tides can be incorporated during DNA replication. In light of
these results a full study of how diﬀerent polymerases (partic-
ularly human) deal with O6-(cm)-dGTP in the dNTP pool during
replication is warranted.
Conclusions
We have discovered a new way to create O6-G adducts post-
synthetically in nucleic acids of varying size, from nucleotide
mono- or triphosphates to long oligonucleotides. The ability to
obtain high yields of precisely dened O6-G adducts eliminates
a major roadblock in studying their biochemistry, a point we
have illustrated through the rst synthesis of O6-(cm)-dGTP and
the rst demonstration of its incorporation during DNA
replication.
Copper-catalysed O6-G alkylation is a dump-and-stir proce-
dure that employs readily available materials. a-Diazo ester
substrates are stable enough that several are sold commercially
and a simple33 two-step (one-pot) protocol for a-diazo ester
synthesis makes nearly any diazo compound in this class
synthetically accessible. Research on O6-G adducts in biology67
and biotechnology68 demands ready synthetic access to these
adducts and the method we have described is the simplest to
date.
Nucleic acids are found in diverse contexts and can fold in
myriad ways, complicating attempts at broad generalizations of
reactivity. Nevertheless, the weight of evidence suggests N7G is
the most powerful nucleophile34 and ligand36 in DNA and RNA.
It is a primary target of organic electrophiles,34 as well as
organometallic anticancer drugs.69 To the list of N7G's func-
tions we add the role of directing group in copper catalysed
reactions. We have focussed on alkylation reactions, but the
same eﬀect is likely responsible for the well-known propensity
of Fenton-type oxidative damage to be localized around
guanines.40
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